MRNA Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
Moderna Inc. Stock Analysis MRNA
United States Health Care Large Cap Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). The company is headquartered in Cambridge, Massachusetts and currently employs 5,800 full-time employees. The company went IPO on 2018-12-07. The firm is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). The company is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Read More MRNA Chart
Moderna Inc vs S&P 500 Comparative Returns
Analysis of MRNA stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- Moderna Inc (MRNA) -41.37%
- S&P 500 -4.27%
Moderna Inc Underperformed S&P 500 by 37.10%
1Y Performance
- Moderna Inc (MRNA) -80%
- S&P 500 8.86%
Moderna Inc Underperformed S&P 500 by 88.86%
3Y Performance
- Moderna Inc (MRNA) -82.05%
- S&P 500 37.21%
Moderna Inc Underperformed S&P 500 by 119.26%
5Y Performance
- Moderna Inc (MRNA) -58.85%
- S&P 500 92.3%
Moderna Inc Underperformed S&P 500 by 151.15%
Key Statistics
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$24.68Volume
9.68MP/E Ratio (TTM)
-52 Week Range
Market Cap
13.18BAvg. Volume
8.92MDividend Yield
-Financial Metrics & Statements
- Per Share Data
- Ratios
- Statements
| Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Revenue per Share (TTM) | 2.01 | 45.83 | 50.03 | 17.93 | - |
EBIT per Share (TTM) | -1.91 | 32.99 | 24.47 | -5.34 | - |
Earnings per Share (EPS) (TTM) | - | 30.31 | 21.26 | -12.33 | - |
EPS Forward | - | - | 20.1 | -12.34 | -9.27 |
Super Investors
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
Joel Greenblatt
% Portfolio:
0.03 Recent Activity:100.00%
Jefferies Group
% Portfolio:
0 Recent Activity:-
Cathie Wood
% Portfolio:
0 Recent Activity:-100.00%
Ken Fisher
% Portfolio:
0 Recent Activity:-100.00%
Community-Curated Collections ( With MRNA )
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
FAQ's
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Alternate Halal Stocks
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
